Skip to main content
TipRanks
Go Ultimate75% OFF

Eldon R Smith Insider Profile

4 Followers

Eldon R Smith, Chairman at Cardiol Therapeutics, holds 1.27M shares in Cardiol Therapeutics (Ticker: CRDL), holds 51.00K shares in Resverlogix (Ticker: TSE:RVX), holds 235.00K shares in IntelliPharmaCeutics International (Ticker: IPCIQ).

Eldon R Smith's Trading History

CRDL
Cardiol Therapeutics
Mar 03, 2021ChairmanUninformative Sell32.50K$1.27M
RVX
Resverlogix
Jun 20, 2019DirectorUninformative Sell9.75KC$3.83K
IPCIQ
IntelliPharmaCeutics International
Dec 05, 2017DirectorUninformative Buy46.00K―
FLOW
Flow Capital Corp
Jan 08, 2016DirectorUninformative Buy40.50KC$341.25K
CNQ
Canadian Natural
Jul 08, 2015FormerUninformative Buy11.16K$912.12K

You May Also Like

Eldon R Smith insider profile FAQ

What is the percentage of profitable transactions made by Eldon R Smith?
The percentage of profitable transactions made by Eldon R Smith is 67%.
What is the average return per transaction made by Eldon R Smith?
The average return per transaction made by Eldon R Smith is -15.40%.
What stocks does Eldon R Smith hold?
Eldon R Smith holds: CRDL, CNQ, IPCIQ, TSE:FLOW, TSE:RVX stocks.
What was Eldon R Smith’s latest transaction?
Eldon R Smith’s latest transaction was an Uninformative Sell of $32.50K.
What was Eldon R Smith's most profitable transaction?
Eldon R Smith’s most profitable transaction was an Informative Buy of CRDL stock on June 9, 2020. The return on the trade was 26.80%.
What is Eldon R Smith's role in Cardiol Therapeutics?
Eldon R Smith's role in Cardiol Therapeutics is Chairman.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.